In early 2024, executives at artificial intelligence start-up Anthropic ramped up an ambitious project they sought to keep quiet. “Project Panama is our effort to destructively scan all the books in ...
Scanners didn’t just put Cronenberg on the map. It marked a shift in his perspective on body horror, which became more distinctly cerebral over the years (as evidenced by the post-human themes in ...
Google has toyed with personalized answers in Gemini, but that was just a hint of what was to come. Today, the company is announcing extensive “personal intelligence” in Gemini that allows the chatbot ...
On January 1, CMS launched its latest alternative payment model: TEAM, the Transforming Episode Accountability Model. The mandatory program requires hundreds of acute care hospitals to participate in ...
Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Kurt Schlosser on Jan 8, 2026 at ...
Navvis Named a Leader in the IDC MarketScape for U.S. Value-Based Care Strategic Consulting Services 2025-2026 Vendor Assessment Navvis' comprehensive capabilities and operational approach accelerate ...
Navvis, the leading value-based care enablement company, today announced the company has been named a Leader in the IDC MarketScape: U.S. Value-Based Care Strategic Consulting Services 2025-2026 ...
Withings has announced the Body Scan 2, a new smart scale that the French health tech company says can track over 60 longitudinal biomarker measurements that enable the early detection of health ...
PONTE VEDRA, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of ...
Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HIT It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results